Daniel Blair, PhD

Two friends and research colleagues are looking at different stages of the immune response to pave the way for enhanced cancer treatments.

An early dream of being an astronaut planted the seeds of exploration and making a difference in this college dean.

A researcher who works with their lab members accomplish more than he or she ever could alone. Learn how Dr. Mark Hatley mentors his postdocs.

Pill swallowing should be easy – imagine the stress when the pills are life-saving and you have a physical condition that makes it difficult – what then?

New treatments have led to new thinking and new approaches to pediatric cancer – and sometimes, a cure isn’t the goal.

High science calls on Star Wars character as a potential ally against Alzheimer’s disease.

St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.

Hiroto Inaba: scientist, pediatric oncologist and "first son" of an old samurai family. His unfortunate enemy: childhood cancer.

A physician scientist updates the St. Jude model of research and clinical care, transforming clinical informatics.

An agreement between one U.S. hospital and two Chinese hospitals in 1991 has completely changed global pediatric cancer care.